Terminology Service < Semantic Lookup Platform

All terms in CHEBI

Label	Id	Description
(2-trans,6-cis)-farnesol	CHEBI_35966	[The (2E,6Z)-stereoisomer of farnesol.]
CHEBI_35978	CHEBI_35978
amoxicilloic acid	CHEBI_60912	[A thiazolidinemonocarboxylic acid obtained via hydrolysis of the beta-lactam ring of amoxicillin.]
amoxicilloate	CHEBI_133943	[A thiazolidinemonocarboxylate anion resulting from proton loss from the carboxy group located on the beta-lactam ring of amoxicilloic acid.]
(2R)-2-[(4R,5S)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-8-(3-methoxyprop-1-ynyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol	CHEBI_106102
ganglioside GT1b	CHEBI_60913	[A sialoheptaosylceramide where the sialoheptaosyl portion contains three sialic acid residues.]
alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer	CHEBI_28058	[A sialotetraosylceramide consisting of a branched heptasaccharide made up from three sialyl residues, two galactose residues, one N-acetylglucosamine residue and a glucose residue at the reducing end attached to the ceramide portion via a beta-linkage.]
alpha-Neu5Ac-(2->3)-beta-Gal-(1->3)-beta-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer(d18:1/18:0)(3-)	CHEBI_88229	[An anionic ganglioside obtained by deprotonation of the neuraminosyl carboxy groups of ganglioside GT1b (d18:1/C18:0); major species at pH 7.3.]
dioxo monocarboxylic acid anion	CHEBI_35979	[An oxo monocarboxylic acid anion that is the conjugate base of dioxo monocarboxylic acid.]
1-[[(4S,5R)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea	CHEBI_106103
sialoheptaosylceramide	CHEBI_60914	[A ganglioside in which the oligosaccharide portion is composed of a heptasaccharide, to which one or more sialic acid residues are attached.]
N-[[(2S,3R)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridinecarboxamide	CHEBI_106104
diastereoisomeric mixture	CHEBI_60915	[A mixture composed of two or more diastereoisomers (stereoisomers not related as mirror images).]
2-(dimethylamino)-N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[2-(3-pyridinyl)ethynyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide	CHEBI_106105
(2R,3S,2'R)-nadolol	CHEBI_60917	[An aromatic ether, being the (2R)-3-(tert-butylamino)-2-hydroxypropyl ether of the phenolic hydroxy group of (6R,7S)-5,6,7,8-tetrahydronaphthalene-1,6,7-triol.]
(2S,3R,2'S)-nadolol	CHEBI_60918	[An aromatic ether, being the (2S)-3-(tert-butylamino)-2-hydroxypropyl ether of the phenolic hydroxy group of (6S,7R)-5,6,7,8-tetrahydronaphthalene-1,6,7-triol.]
(2S)-2-[(4R,5R)-4-methyl-8-(4-methylphenyl)-5-[[methyl(5-pyrimidinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol	CHEBI_106100
(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one	CHEBI_106101
CHEBI_21330	CHEBI_21330
CHEBI_21331	CHEBI_21331